Skeletal Gene Expression in Nuclear Microenvironments

Principles of Bone Biology: Volume 1-2, Third Edition

Volumn , Issue , 2008, Pages 263-283

  Stein, Gary S ^a   Lian, Jane B ^a   Montecino, Martin ^b   van Wijnen, André J ^a   Stein, Janet L ^a   Javed, Amjad ^a   Young, Daniel W ^c   Hassan, Mohammad Q ^a   Zaidi, Sayyed K ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CONCEPCIÓN   (Chile)

^c NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882538120     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-373884-4.00033-1     Document Type: Chapter

References (134)

1. C. Banerjee, L.R. McCabe, J.-Y. Choi, S.W. Hiebert, J.L. Stein, G.S. Stein and J.B. Lian (1997) Runt homology domain proteins in osteoblast differentiation: AML-3/CBFA1 is a major component of a bone specific complex. J. Cell. Biochem. 66 1-8.
2. G.L. Barnes, K.E. Hebert, M. Kamal, A. Javed, T.A. Einhorn, J.B. Lian, G.S. Stein and L.C. Gerstenfeld (2004) Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases associated osteolytic disease. Cancer Res. 64 4506-4513.
3. P.B. Becker and W. Horz (2002) ATP-dependent nucleosome remodeling. Annu. Rev. Biochem. 71 247-273.
4. A. Bellahcene, S. Menard, R. Bufalino, L. Moreau and V. Castronovo (1996) Expression of bone sialoprotein in primary human breast cancer is associated with poor survival. Int. J. Cancer 69 350-353.
5. R. Berezney and D.S. Coffey (1975) Nuclear protein matrix: Association with newly synthesized DNA. Science 189 291-293.
6. R. Berezney and K.W. Jeon (1995) Structural and Functional Organization of the Nuclear Matrix. San Diego, Calif: Academic Press
7. R. Berezney and X. Wei (1998) The new paradigm: integrating genomic function and nuclear architecture. J. Cell Biochem. Suppl. 30–31 238-242.
8. B.E. Bernstein, A. Meissner and E.S. Lander (2007) The mammalian epigenome. Cell 128 669-681.
9. J.P. Bidwell, E.G. Fey, A.J. van Wijnen, S. Penman, J.L. Stein, J.B. Lian and G.S. Stein (1994) Nuclear matrix proteins distinguish normal diploid osteoblasts from osteosarcoma cells. Cancer Res. 54 28-32.
10. B.J. Blencowe, J.A. Nickerson, R. Issner, S. Penman and P.A. Sharp (1994) Association of nuclear matrix antigens with exon-containing splicing complexes. J. Cell Biol. 127 593-607.
11. H. Boeger, J. Griesenbeck, J.S. Strattan and R.D. Kornberg (2004) Removal of promoter nucleosomes by disassembly rather than sliding in vivo. Mol. Cell 14 667-673.
12. V.H. Bramwell, G.S. Doig, A.B. Tuck, S.M. Wilson, K.S. Tonkin, A. Tomiak, F. Perera, T.A. Vandenberg and A.F. Chambers (2006) Serial plasma osteopontin levels have prognostic value in metastatic breast cancer. Clin. Cancer Res. 12 3337-3343.
13. M.R. Branco and A. Pombo (2007) Chromosome organization: New facts, new models. Trends Cell Biol. 17 127-134.
14. D. Burakov, L.A. Crofts, C.P. Chang and L.P. Freedman (2002) Reciprocal recruitment of DRIP/mediator and p160 coactivator complexes in vivo by estrogen receptor. J. Biol. Chem. 277 14359-14362.
15. S. Cai, C.C. Lee and T. Kohwi-Shigematsu (2006) SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. Nat. Genet. 38 1278-1288.
16. L. Carvallo, B. Henriquez, J. Olate, A. van Wijnen, J.B. Lian, G.S. Stein, S. Onate, J.L. Stein and M. Montecino (2007) The 1α, 25-dihydroxy vitamin D3 receptor preferentially recruits the coactivator SRC-1 during up-regulation of the osteocalcin gene. J. Steroid Biochem. Mol. Biol. 103 420-424.
17. W. Chang, M. Parra, C. Ji, Y. Liu, O. Eickelberg, T.L. McCarthy and M. Centrella (2002) Transcriptional and post-transcriptional regulation of transforming growth factor beta type II receptor expression in osteoblasts. Gene 299 65-77.
18. L.F. Chen, K. Ito, Y. Murakami and Y. Ito (1998) The capacity of polyomavirus enhancer binding protein 2αB (AML1/Cbfa2) to stimulate polyomavirus DNA replication is related to its affinity for the nuclear matrix. Mol. Cell Biol. 18 4165-4176.
19. J.M. Chirgwin, K.S. Mohammad and T.A. Guise (2004) Tumor–bone cellular interactions in skeletal metastases. J. Musculoskelet. Neuronal Interact. 4 308-318.
20. S. Christakos, P. Dhawan, Y. Liu, X. Peng and A. Porta (2003) New insights into the mechanisms of vitamin D action. J. Cell Biochem. 88 695-705.
21. A.L. Clayton, C.A. Hazzalin and L.C. Mahadevan (2006) Enhanced histone acetylation and transcription: a dynamic perspective. Mol. Cell 23 289-296.
22. T. Cremer, M. Cremer, S. Dietzel, S. Muller, I. Solovei and S. Fakan (2006) Chromosome territories—a functional nuclear landscape. Curr. Opin. Cell Biol. 18 307-316.
23. J.R. Davie (1997) Nuclear matrix, dynamic histone acetylation and transcriptionally active chromatin. Mol. Biol. Rep. 24 197-207.
24. I. de la Serna, K.A. Carlson, D.A. Hill, C.J. Guidi, R.O. Stephenson, S. Sif, R.E. Kingston and A.N. Imbalzano (2000) Mammalian SWI–SNF complexes contribute to activation of the hsp70 gene. Mol. Cell Biol. 20 2839-2851.
25. I. de la Serna, K.A. Carlson and A.N. Imbalzano (2001) Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation. Nat. Genet. 27 187-190.
26. I. de la Serna, K. Roy, K.A. Carlson and A.N. Imbalzano (2001) MyoD can induce cell cycle arrest but not muscle differentiation in the presence of dominant negative SWI/SNF chromatin remodeling enzymes. J Biol. Chem. 276 41486-41491.
27. I. de la Serna, Y. Ohkawa and A.N. Imbalzano (2006) Chromatin remodelling in mammalian differentiation: Lessons from ATP-dependent remodellers. Nat. Rev. Genet. 7 461-473.
28. G. Dobreva, M. Chahrour, M. Dautzenberg, L. Chirivella, B. Kanzler, I. Farinas, G. Karsenty and R. Grosschedl (2006) SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell 125 971-986.
29. B. Drobic, K.L. Dunn, P.S. Espino and J.R. Davie (2006) Abnormalities of chromatin in tumor cells. EXS (96), 25-47.
30. S.I. Dworetzky, E.G. Fey, S. Penman, J.B. Lian, J.L. Stein and G.S. Stein (1990) Progressive changes in the protein composition of the nuclear matrix during rat osteoblast differentiation. Proc. Natl. Acad. Sci. USA 87 4605-4609.
31. M. Egeblad and Z. Werb (2002) New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2 161-174.
32. H. Enomoto, S. Shiojiri, K. Hoshi, T. Furuichi, R. Fukuyama, C.A. Yoshida, N. Kanatani, R. Nakamura, A. Mizuno, A. Zanma, K. Yano, H. Yasuda, K. Higashio, K. Takada and T. Komori (2003) Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2−/− mice by RANKL transgene. J. Biol. Chem. 278 23971-23977.
33. B.T. Feeley, S.C. Gamradt, W.K. Hsu, N. Liu, L. Krenek, P. Robbins, J. Huard and J.R. Lieberman (2005) Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer. J. Bone Miner. Res. 20 2189-2199.
34. K. Fizazi, J. Yang, S. Peleg, C.R. Sikes, E.L. Kreimann, D. Daliani, M. Olive, K.A. Raymond, T.J. Janus, C.J. Logothetis, G. Karsenty and N.M. Navone (2003) Prostate cancer cells–osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts. Clin. Cancer Res. 9 2587-2597.
35. C.K. Glass and M.G. Rosenfeld (2000) The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14 121-141.
36. R.H. Goodman and S. Smolik (2000) CBP/p300 in cell growth, transformation, and development. Genes Dev. 14 1553-1577.
37. S.L. Grimm and J.M. Rosen (2006) Stop! In the name of transforming growth factor-beta: Keeping estrogen receptor-alpha-positive mammary epithelial cells from proliferating. Breast Cancer Res. 8 106.
38. T.A. Guise and J.M. Chirgwin (2003) Transforming growth factor-beta in osteolytic breast cancer bone metastases. Clin. Orthop. S32-S38.
39. B. Guo, P.R. Odgren, A.J. van Wijnen, T.J. Last, J. Nickerson, S. Penman, J.B. Lian, J.L. Stein and G.S. Stein (1995) The nuclear matrix protein NMP-1 is the transcription factor YY1. Proc. Natl. Acad. Sci. USA 92 10526-10530.
40. J. Gutierrez, J. Sierra, R. Medina, M. Puchi, M. Imschenetzky, S. Hiebert, A. van Wijnen, J.B. Lian, G. Stein, J. Stein and M. Montecino (2000) Interaction of CBFa/AML/PEBP2a transcription factors with nucleosomal sequences requires flexibility in the translational positioning of the histone octamer and exposure of the Cbfa site. Biochemistry 39 13565-13574.
41. S. Gutierrez, A. Javed, D. Tennant, M. van Rees, M. Montecino, G.S. Stein, J.L. Stein and J.B. Lian (2002) CCAAT/enhancer-binding proteins (C/EBP) β and δ activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. J. Biol. Chem. 277 1316-1323.
42. J. Gutierrez, R. Paredes, F. Cruzat, D.A. Hill, A.J. van Wijnen, J.B. Lian, G.S. Stein, J.L. Stein, A.N. Imbalzano and M. Montecino (2007) Chromatin remodeling by SWI/SNF results in nucleosome mobilization to preferential positions in the rat osteocalcin gene promoter. J Biol. Chem. 282 9445-9457.
43. J.L. Gutierrez, M. Chandy, M.J. Carrozza and J.L. Workman (2007) Activation domains drive nucleosome eviction by SWI/SNF. EMBO J. 26 730-740.
44. Y. Hirose and J.L. Manley (2000) RNA polymerase II and the integration of nuclear events. Genes Dev. 14 1415-1429.
45. H. Htun, J. Barsony, I. Renyi, D.L. Gould and G.L. Hager (1996) Visualization of glucocorticoid receptor translocation and intranuclear organization in living cells with a green fluorescent protein chimera. Proc. Natl. Acad. Sci. USA 93 4845-4850.
46. A. Javed, S. Gutierrez, M. Montecino, A.J. van Wijnen, J.L. Stein, G.S. Stein and J.B. Lian (1999) Multiple Cbfa/AML sites in the rat osteocalcin promoter are required for basal and vitamin D responsive transcription and contribute to chromatin organization. Mol. Cell. Biol. 19 7491-7500.
47. A. Javed, B. Guo, S. Hiebert, J.-Y. Choi, J. Green, S.-C. Zhao, M.A. Osborne, S. Stifani, J.L. Stein, J.B. Lian, A.J. van Wijnen and G.S. Stein (2000) Groucho/TLE/R-Esp proteins associate with the nuclear matrix and repress RUNX (CBFa/AML/PEBP2a) dependent activation of tissue-specific gene transcription. J. Cell Sci. 113 2221-2231.
48. A. Javed, G.L. Barnes, J. Pratap, T. Antkowiak, L.C. Gerstenfeld, A.J. van Wijnen, J.L. Stein, J.B. Lian and G.S. Stein (2005) Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo. Proc. Natl. Acad. Sci. USA 102 1454-1459.
49. C. Ji, O. Eickelberg, T.L. McCarthy and M. Centrella (2001) Control and counter-control of TGF-beta activity through FAST and Runx (CBFa) transcriptional elements in osteoblasts. Endocrinology 142 3873-3879.
50. S.M. Kakonen, K.S. Selander, J.M. Chirgwin, J.J. Yin, S. Burns, W.A. Rankin, B.G. Grubbs, M. Dallas, Y. Cui and T.A. Guise (2002) Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways. J. Biol. Chem. 277 24571-24578.
51. J.S. Kang, T. Alliston, R. Delston and R. Derynck (2005) Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3. EMBO J. 24 2543-2555.
52. S. Kim, N.K. Shevde and J.W. Pike (2005) 1, 25–Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J. Bone Miner. Res. 20 305-317.
53. P. Korber, S. Barbaric, T. Luckenbach, A. Schmid, U.J. Schermer, D. Blaschke and W. Horz (2006) The histone chaperone Asf1 increases the rate of histone eviction at the yeast PHO5 and PHO8 promoters. J. Biol. Chem. 281 5539-5545.
54. R.D. Kornberg (2005) Mediator and the mechanism of transcriptional activation. Trends Biochem. Sci. 30 235-239.
55. S.T. Kosak and M. Groudine (2004) Gene order and dynamic domains. Science 306 644-647.
56. T. Kouzarides (2007) Chromatin modifications and their function. Cell 128 693-705.
57. B. Lemon and R. Tjian (2000) Orchestrated response: A symphony of transcription factors for gene control. Genes Dev. 14 2551-2569.
58. H. Leonhardt, H.P. Rahn, P. Weinzierl, A. Sporbert, T. Cremer, D. Zink and M.C. Cardoso (2000) Dynamics of DNA replication factories in living cells. J Cell Biol. 149 271-280.
59. B. Li, M. Carey and J.L. Workman (2007) The role of chromatin during transcription. Cell 128 707-719.
60. J.B. Lian, A. Javed, S.K. Zaidi, C. Lengner, M. Montecino, A.J. van Wijnen, J.L. Stein and G.S. Stein (2004) Regulatory controls for osteoblast growth and differentiation: Role of Runx/Cbfa/AML factors. Crit Rev. Eukaryot. Gene Expr. 14 1-41.
61. H. Liu, N. Mulholland, H. Fu and K. Zhao (2006) Cooperative activity of BRG1 and Z-DNA formation in chromatin remodeling. Mol. Cell Biol. 26 2550-2559.
62. J.G. McNally, W.G. Muller, D. Walker, R. Wolford and G.L. Hager (2000) The glucocorticoid receptor: Rapid exchange with regulatory sites in living cells. Science 287 1262-1265.
63. S. McNeil, B. Guo, J.L. Stein, J.B. Lian, S. Bushmeyer, E. Seto, M.L. Atchison, S. Penman, A.J. van Wijnen and G.S. Stein (1998) Targeting of the YY1 transcription factor to the nucleolus and the nuclear matrix in situ: The C-terminus is a principal determinant for nuclear trafficking. J. Cell. Biochem. 68 500-510.
64. S. McNeil, C. Zeng, K.S. Harrington, S. Hiebert, J.B. Lian, J.L. Stein, A.J. van Wijnen and G.S. Stein (1999) The t(8;21) chromosomal translocation in acute myelogenous leukemia modifies intranuclear targeting of the AML1/CBFalpha2 transcription factor. Proc. Natl. Acad. Sci. USA 96 14882-14887.
65. H.L. Merriman, A.J. van Wijnen, S. Hiebert, J.P. Bidwell, E. Fey, J. Lian, J. Stein and G.S. Stein (1995) The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: Interactions with the osteocalcin gene promoter. Biochemistry 34 13125-13132.
66. R. Metivier, G. Penot, M.R. Hubner, G. Reid, H. Brand, M. Kos and F. Gannon (2003) Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115 751-763.
67. R. Metivier, G. Reid and F. Gannon (2006) Transcription in four dimensions: Nuclear receptor-directed initiation of gene expression. EMBO Rep. 7 161-167.
68. T. Misteli (2000) Cell biology of transcription and pre-mRNA splicing: Nuclear architecture meets nuclear function. J. Cell Sci. 113 1841-1849.
69. T. Misteli (2004) Spatial positioning; a new dimension in genome function. Cell 119 153-156.
70. R.D. Moir, M. Yoon, S. Khuon and R.D. Goldman (2000) Nuclear lamins A and B1. Different pathways of assembly during nuclear envelope formation in living cells. J Cell Biol. 151 1155-1168.
71. M. Montecino, B. Frenkel, A.J. van Wijnen, J.B. Lian, G.S. Stein and J.L. Stein (1999) Chromatin hyperacetylation abrogates vitamin D–mediated transcriptional upregulation of the tissue-specific osteocalcin gene in vivo. Biochemistry 38 1338-1345.
72. M. Montecino, G.S. Stein, F. Cruzat, S. Marcellini, J.L. Stein, J.B. Lian, A.J. van Wijnen and G. Arriagada (2007) An architectural perspective of vitamin D responsiveness. Arch. Biochem. Biophys. 460 293-299.
73. G.J. Narlikar, H.Y. Fan and R.E. Kingston (2002) Cooperation between complexes that regulate chromatin structure and transcription. Cell 108 475-487.
74. M.T.A. Nguyen and A.C. Karaplis (1998) The nucleus: A target site for parathyroid hormone-related peptide (PTHrP) action. J. Cell. Biochem. 70 193-199.
75. Y. Oda, C. Sihlbom, R.J. Chalkley, L. Huang, C. Rachez, C.P. Chang, A.L. Burlingame, L.P. Freedman and D.D. Bikle (2003) Two distinct coactivators, DRIP/mediator and SRC/p160, are differentially involved in vitamin D receptor transactivation during keratinocyte differentiation. Mol. Endocrinol. 17 2329-2339.
76. T.A. Owen, M. Aronow, V. Shalhoub, L.M. Barone, L. Wilming, M.S. Tassinari, M.B. Kennedy, S. Pockwinse, J.B. Lian and G.S. Stein (1990) Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J. Cell Physiol. 143 420-430.
77. R. Paredes, J. Gutierrez, S. Gutierrez, L. Allison, M. Puchi, M. Imschenetzky, A. van Wijnen, J. Lian, G. Stein, J. Stein and M. Montecino (2002) Interaction of the 1α, 25-dihydroxyvitamin D3 receptor at the distal promoter region of the bone-specific osteocalcin gene requires nucleosomal remodelling. Biochem. J. 363 667-676.
78. R. Paredes, G. Arriagada, F. Cruzat, A. Villagra, J. Olate, K. Zaidi, A.J. van Wijnen, J.B. Lian, G.S. Stein, J.L. Stein and M. Montecino (2004) The bone-specific transcription factor RUNX2 interacts with the 1α, 25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells. Mol. Cell. Biol. 24 8847-8861.
79. T. Pederson (2000) Half a century of “the nuclear matrix. Mol. Biol. Cell 11 799-805.
80. S. Penman (1995) Rethinking cell structure. Proc. Natl. Acad. Sci. USA 92 5251-5257.
81. C.L. Peterson (2002) Chromatin remodeling enzymes: Taming the machines. Third in review series on chromatin dynamics. EMBO Rep. 3 319-322.
82. J. Pratap, A. Javed, L.R. Languino, A.J. van Wijnen, J.L. Stein, G.S. Stein and J.B. Lian (2005) The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol. Cell. Biol. 25 8581-8591.
83. J. Pratap, J.B. Lian, A. Javed, G.L. Barnes, A.J. van Wijnen, J.L. Stein and G.S. Stein (2006) Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone. Cancer Metastasis Rev. 25 589-600.
84. C. Rachez and L.P. Freedman (2000) Mechanisms of gene regulation by vitamin D3 receptor: A network of coactivator interactions. Gene 246 9-21.
85. C. Rachez, B.D. Lemon, Z. Suldan, V. Bromleigh, M. Gamble, A.M. Naar, H. Erdjument-Bromage, P. Tempst and L.P. Freedman (1999) Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398 824-828.
86. C. Rachez, M. Gamble, C.P. Chang, G.B. Atkins, M.A. Lazar and L.P. Freedman (2000) The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes. Mol. Cell Biol. 20 2718-2726.
87. V. Ramakrishnan (1997) Histone structure and the organization of the nucleosome. Annu. Rev. Biophys. Biomol. Struct. 26 83-112.
88. H. Reinke and W. Horz (2003) Histones are first hyperacetylated and then lose contact with the activated PHO5 promoter. Mol. Cell 11 1599-1607.
89. T.J. Richmond and C.A. Davey (2003) The structure of DNA in the nucleosome core. Nature 423 145-150.
90. D. Rogaia, F. Grignani, R. Carbone, D. Riganelli, F. LoCoco, T. Nakamura, C.M. Croce, P.P. Di Fiore and P.G. Pelicci (1997) The localization of the HRX/ALL1 protein to specific nuclear subdomains is altered by fusion with its eps15 translocation partner. Cancer Res. 57 799-802.
91. J.D. Rowley (1998) The critical role of chromosome translocations in human leukemias. Annu. Rev. Genet. 32 495-519.
92. N. Sadoni, M.C. Cardoso, E.H. Stelzer, H. Leonhardt and D. Zink (2004) Stable chromosomal units determine the spatial and temporal organization of DNA replication. J. Cell Sci. 117 5353-5365.
93. N. Salma, H. Xiao, E. Mueller and A.N. Imbalzano (2004) Temporal recruitment of transcription factors and SWI/SNF chromatin-remodeling enzymes during adipogenic induction of the peroxisome proliferator-activated receptor gamma nuclear hormone receptor. Mol. Cell Biol. 24 4651-4663.
94. N. Selvamurugan, S. Kwok and N.C. Partridge (2004) Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-β1–stimulated collagenase-3 expression in human breast cancer cells. J. Biol. Chem. 279 27764-27773.
95. D. Sharma and J.D. Fondell (2002) Ordered recruitment of histone acetyltransferases and the TRAP/Mediator complex to thyroid hormone-responsive promoters in vivo. Proc. Natl. Acad. Sci. USA 99 7934-7939.
96. J.A. Sharp, M. Waltham, E.D. Williams, M.A. Henderson and E.W. Thompson (2004) Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice. Clin. Exp. Metastasis 21 19-29.
97. J. Shen, M.A. Montecino, J.B. Lian, G.S. Stein, A.J. van Wijnen and J.L. Stein (2002) Histone acetylation in vivo at the osteocalcin locus is functionally linked to vitamin D dependent, bone tissue-specific transcription. J. Biol. Chem. 277 20284-20292.
98. J. Sierra, A. Villagra, R. Paredes, F. Cruzat, S. Gutierrez, A. Javed, G. Arriagada, J. Olate, M. Imschenetzky, A.J. van Wijnen, J.B. Lian, G.S. Stein and J.L. Stein (2003) Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity. Mol. Cell Biol. 23 3339-3351.
99. P.J. Skinner, B.T. Koshy, C.J. Cummings, I.A. Klement, K. Helin, A. Servadio, H.Y. Zoghbi and H.T. Orr (1997) Ataxin-1 with an expanded glutamine tract alters nuclear matrix- associated structures. Nature 389 971-974.
100. D.L. Spector (2001) Nuclear domains. J. Cell Sci. 114 2891-2893.
101. G.S. Stein, S.K. Zaidi, C.D. Braastad, M. Montecino, A.J. van Wijnen, J.-Y. Choi, J.L. Stein, J.B. Lian and A. Javed (2003) Functional architecture of the nucleus: Organizing the regulatory machinery for gene expression, replication and repair. Trends Cell Biol. 13 584-592.
102. D. Stenoien, Z.D. Sharp, C.L. Smith and M.A. Mancini (1998) Functional subnuclear partitioning of transcription factors. J. Cell. Biochem 70 213-221.
103. D.J. Taatjes, M.T. Marr and R. Tjian (2004) Regulatory diversity among metazoan co-activator complexes. Nat. Rev. Mol. Cell Biol. 5 403-410.
104. L. Tang, B. Guo, A.J. van Wijnen, J.B. Lian, J.L. Stein, G.S. Stein and G.W. Zhou (1998) Preliminary crystallographic study of the glutathione S-transferase fused with the nuclear matrix targeting signal of the transcription factor AML-1/CBFa2. J. Struct. Biol. 123 83-85.
105. Y. Tang, R.H. Getzenberg, B.N. Vietmeier, M.R. Stallcup, M. Eggert, R. Renkawitz and D.B. DeFranco (1998) The DNA-binding and t2 transactivation domains of the rat glucocorticoid ­receptor constitute a nuclear matrix targeting signal. Mol. Endocrinol. 12 1420-1431.
106. L. Tang, B. Guo, A. Javed, J.-Y. Choi, S. Hiebert, J.B. Lian, A.J. van Wijnen, J.L. Stein, G.S. Stein and G.W. Zhou (1999) Crystal structure of the nuclear matrix targeting signal of the transcription factor AML-1/PEBP2aB/CBFa2. J. Biol. Chem. 274 33580-33586.
107. W. Tao and A.J. Levine (1999) Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2– mediated degradation of p53. Proc. Natl. Acad. Sci. USA 96 3077-3080.
108. A. Thastrom, L.M. Bingham and J. Widom (2004) Nucleosomal locations of dominant DNA sequence motifs for histone–DNA interactions and nucleosome positioning. J. Mol. Biol. 338 695-709.
109. S. Vaisanen, T.W. Dunlop, L. Sinkkonen, C. Frank and C. Carlberg (2005) Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1α, 25-dihydroxyvitamin D3. J. Mol. Biol. 350 65-77.
110. M. van Driel, H.A. Pols and J.P. Van Leeuwen (2004) Osteoblast differentiation and control by vitamin D and vitamin D metabolites. Curr. Pharm. Des. 10 2535-2555.
111. B. van Steensel, G. Jenster, K. Damm, A.O. Brinkmann and R. van Driel (1995) Domains of the human androgen receptor and glucocorticoid receptor involved in binding to the nuclear matrix. J. Cell. Biochem. 57 465-478.
112. A.J. van Wijnen, J.P. Bidwell, E.G. Fey, S. Penman, J.B. Lian, J.L. Stein and G.S. Stein (1993) Nuclear matrix association of multiple sequence-specific DNA binding activities related to SP-1, ATF, CCAAT, C/EBP, OCT-1, and AP-1. Biochemistry 32 8397-8402.
113. P.J. Verschure, I. van Der Kraan, E.M. Manders and R. van Driel (1999) Spatial relationship between transcription sites and chromosome territories. J. Cell Biol. 147 13-24.
114. A. Villagra, F. Cruzat, L. Carvallo, R. Paredes, J. Olate, A.J. van Wijnen, G.S. Stein, J.B. Lian, J.L. Stein, A.N. Imbalzano and M. Montecino (2006) Chromatin remodeling and transcriptional activity of the bone-specific osteocalcin gene require CCAAT/enhancer-binding protein beta-dependent recruitment of SWI/SNF activity. J. Biol. Chem. 281 22695-22706.
115. D. Vradii, S.K. Zaidi, J.B. Lian, A.J. van Wijnen, J.L. Stein and G.S. Stein (2005) A point mutation in AML1 disrupts subnuclear targeting, prevents myeloid differentiation, and results in a transformation-like phenotype. Proc. Natl. Acad. Sci. USA 102 7174-7179.
116. Q. Wang, J.S. Carroll and M. Brown (2005) Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol. Cell 19 631-642.
117. K. Weis, S. Rambaud, C. Lavau, J. Jansen, T. Carvalho, M. Carmo-Fonseca, A. Lamond and A. Dejean (1994) Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell 76 345-356.
118. J.L. Workman (2006) Nucleosome displacement in transcription. Genes Dev. 20 2009-2017.
119. J. Xu and B.W. O’Malley (2002) Molecular mechanisms and cellular biology of the steroid receptor coactivator (SRC) family in steroid receptor function. Rev. Endocr. Metab. Disord. 3 185-192.
120. T. Yano, T. Nakamura, J. Blechman, C. Sorio, C.V. Dang, B. Geiger and E. Canaani (1997) Nuclear punctate distribution of ALL-1 is conferred by distinct elements at the N terminus of the protein. Proc. Natl. Acad. Sci. USA 94 7286-7291.
121. T. Yoneda, P.J. Williams, T. Hiraga, M. Niewolna and R. Nishimura (2001) A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner. Res. 16 1486-1495.
122. D.W. Young, S.K. Zaidi, P.S. Furcinitti, A. Javed, A.J. van Wijnen, J.L. Stein, J.B. Lian and G.S. Stein (2004) Quantitative signature for architectural organization of regulatory factors using intranuclear informatics. J. Cell Sci. 117 4889-4896.
123. D.W. Young, J. Pratap, A. Javed, B. Weiner, Y. Ohkawa, A. van Wijnen, M. Montecino, G.S. Stein, J.L. Stein, A.N. Imbalzano and J.B. Lian (2005) SWI/SNF chromatin remodeling complex is obligatory for BMP2-induced, Runx2-dependent skeletal gene expression that controls osteoblast differentiation. J. Cell Biochem. 94 720-730.
124. D.W. Young, M.Q. Hassan, J. Pratap, M. Galindo, S.K. Zaidi, S. Lee, X. Yang, R. Xie, J. Underwood, P. Furcinitti, A.N. Imbalzano, S. Penman, J.A. Nickerson, M.A. Montecino, J.B. Lian, J.L. Stein, A.J. van Wijnen and G.S. Stein (2007) Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2. Nature 445 442-446.
125. D.W. Young, M.Q. Hassan, X.-Q. Yang, M. Galindo, A. Javed, S.K. Zaidi, P. Furcinitti, D. Lapointe, M. Montecino, J.B. Lian, J.L. Stein, A.J. van Wijnen and G.S. Stein (2007) Mitotic retention of gene expression patterns by the cell fate determining transcription factor Runx2. Proc. Natl. Acad. Sci. USA 104 3189-3194.
126. S.K. Zaidi, A. Javed, J.-Y. Choi, A.J. van Wijnen, J.L. Stein, J.B. Lian and G.S. Stein (2001) A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene. J. Cell Sci. 114 3093-3102.
127. S.K. Zaidi, D.W. Young, S.H. Pockwinse, A. Javed, J.B. Lian, J.L. Stein, A.J. van Wijnen and G.S. Stein (2003) Mitotic partitioning and selective reorganization of tissue specific transcription factors in progeny cells. Proc. Natl. Acad. Sci. USA 100 14852-14857.
128. S.K. Zaidi, A.J. Sullivan, R. Medina, Y. Ito, A.J. van Wijnen, J.L. Stein, J.B. Lian and G.S. Stein (2004) Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. EMBO J. 23 790-799.
129. S.K. Zaidi, D.W. Young, A. Javed, J. Pratap, M. Montecino, W.A. van, J.B. Lian, J.L. Stein and G.S. Stein (2007) Nuclear microenvironments in biological control and cancer. Nat. Rev. Cancer 7 454-463.
130. E. Zelzer, D.J. Glotzer, C. Hartmann, D. Thomas, N. Fukai, S. Soker and B.R. Olsen (2001) Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech. Dev. 106 97-106.
131. C. Zeng, A.J. van Wijnen, J.L. Stein, S. Meyers, W. Sun, L. Shopland, J.B. Lawrence, S. Penman, J.B. Lian, G.S. Stein and S.W. Hiebert (1997) Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBFa transcription factors. Proc. Natl. Acad. Sci. USA 94 6746-6751.
132. C. Zeng, S. McNeil, S. Pockwinse, J.A. Nickerson, L. Shopland, J.B. Lawrence, S. Penman, S.W. Hiebert, J.B. Lian, A.J. van Wijnen, J.L. Stein and G.S. Stein (1998) Intranuclear targeting of AML/CBFa regulatory factors to nuclear matrix-associated transcriptional domains. Proc. Natl. Acad. Sci. USA 95 1585-1589.
133. Y.W. Zhang, N. Yasui, N. Kakazu, T. Abe, K. Takada, S. Imai, M. Sato, S. Nomura, T. Ochi, S. Okuzumi, H. Nogami, T. Nagai, H. Ohashi and Y. Ito (2000) PEBP2αA/CBFA1 mutations in Japanese cleidocranial dysplasia patients. Gene 244 21-28.
134. D. Zink, A.H. Fischer and J.A. Nickerson (2004) Nuclear structure in cancer cells. Nat. Rev. Cancer 4 677-687.